본문 바로가기
KERD
논문KCI 등재

Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report

Faruk Uguz|Erdinc Cicek|Ismet Esra Cicek
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2017.05|Clinical Psychopharmacology and Neuroscience|제15권 제2호|pp. 184-186|DOI https://doi.org/10.9758/cpn.2017.15.2.184

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

EdemaLong-acting injectablePaliperidone palmitate.

초록

Peripheral edema is observed as an adverse effect of the usage of antipsychotics in the literature. This case report describes a 36-year-old female patient with the diagnosis of paranoid schizophrenia who presented with pretibial edema following initiation of long-acting injectable paliperidone palmitate. Pretibial edema developed within the second week of treatment and completely disappeared after its discontinuation.

Abstract

Peripheral edema is observed as an adverse effect of the usage of antipsychotics in the literature. This case report describes a 36-year-old female patient with the diagnosis of paranoid schizophrenia who presented with pretibial edema following initiation of long-acting injectable paliperidone palmitate. Pretibial edema developed within the second week of treatment and completely disappeared after its discontinuation.

참고문헌 (17)

  1. Gilday E, "Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia", Rev Recent Clin Trials, 7, pp.2~9 (2012)
  2. Taylor D, "Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review", Br J Psychiatry Suppl, 52, pp.S13~S19 (2009)
  3. Gopal S, "Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia", Curr Med Res Opin, 26, pp.377~387 (2010)
  4. Chwieduk CM, "Paliperidone extended release : a review of its use in the management of schizophrenia", Drugs, 70, pp.1295~1317 (2010)
  5. Samtani MN, "Dosing and switching strategies for paliperidone palmitate : based on population pharmacokinetic modelling and clinical trial data", CNS Drugs, 25, pp.829~845 (2011)
  6. Yang HN, "Peripheral edema associated with risperidone oral solution : a case report and a review of the literature", J Clin Psychopharmacol, 32, pp.128~130 (2012)
  7. Pelizza L, "Long-acting risperidone-induced periorbital edema", J Clin Psychopharmacol, 28, pp.709~710 (2008)
  8. Mathan K, "Olanzapine-induced tender pitting pre-tibial edema", J Pharmacol Pharmacother, 6, pp.114~115 (2015)
  9. O'Connor N, "Quetiapine causing peripheral oedema", Australas Psychiatry, 17, pp.511~512 (2009)
  10. Chen CK, "Amisulpride-associated pedal edema", Eur Psychiatry, 19, pp.454~455 (2004)
  11. Ku HL, "Ziprasidone-associated pedal edema in the treatment of schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.963~964 (2006)
  12. Chen HJ, "Paliperidone-related peripheral edema : a case report and review of the literature", J Clin Psychopharmacol, 34, pp.269~271 (2014)
  13. Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
  14. Sanders RD, "Edema associated with addition of risperidone to valproate treatment", J Clin Psychiatry, 59, pp.689~690 (1998)
  15. Hosseini SH, "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case Rep Med, 2012, pp.540732~ (2012)
  16. Feroz-Nainar C, "Risperidone induced oedema in a child with learning disability and autism", Autism, 10, pp.308~310 (2006)
  17. Ng B, "Peripheral oedema in patients taking olanzapine", Int Clin Psychopharmacol, 18, pp.57~59 (2003)

관련 논문AI추천

Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case ReportJungmin Woo, Seoyoung Jang대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2017 · 제15권 제3호Paliperidone Palmitate-induced Urinary Incontinence: A Case ReportAli Çayköylü, Elvan Özalp, Ersin Hatice Karslıoglu대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제1호Olanzapine-induced Orthostatic HypotensionAmlan Kusum Jana, Nirmalya Roy, Samir Kumar Praharaj대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2015 · 제13권 제1호Aripiprazole Long-acting Injectable Two-injection Start to Manage Supersensitivity Psychosis: A Case ReportHazal Yavuzlar Civan대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2025 · 제23권 제4호Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial강남인, 구본훈, 김성완, 김종훈, 남우범, 이봉주, 이상혁, 이승재, 이승환, 정명훈, 정영철, 한상우대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제3호The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study전덕인, 정명훈, 홍현주, Daeyoung Roh, Jung-Seo Yi, Narei Hong, So-Young Oh대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2019 · 제17권 제4호

이 간행물의 다른 논문 (15건)

Role of Sleep Disturbance in the Trajectory of Alzheimer’s DiseaseChang-Uk Lee, Dong Woo Kang, Hyun Kook Limpp. 89-99Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic ImplicationsAther Muneerpp. 100-114In Silico Model-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia PathophysiologyRimjhim Agrawal, Ganesan Venkatasubramanian, Sunil Vasu Kalmadypp. 115-125Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled TrialYoung Joon Hong, Kyung-Yeol Bae, Jin Sang Yoon, Sung-Wan Kim, Young Keun Ahn, Il-Seon Shin, Jae-Min Kim, Myung Ho Jeong, Hee-Ju Kangpp. 126-131Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with SchizophreniaNakao Iwata, Masakazu Hatano, Shigeki Yamada, Ippei Takeuchi, Manako Hanya, Hiroyuki Kamei, Junji Uno, Kiyoshi Fujita, Azusa Katopp. 132-137
원문 보기